PORKEROpen the app

Senate bill · 109th Congress · Did not become law

Pharmaceutical Market Access and Drug Safety Act of 2005

S. 334Introduced Feb 9, 2005Policy area: Health
Sponsor: Sen. Byron Dorgan D-ND
Open in Bill Explorer →

Where it went

Latest action: Apr 19, 2005 — Committee on Health, Education, Labor, and Pensions. Hearings held. Hearings printed: S.Hrg. 109-143.

Vote results

No recorded roll-call votes on this bill in PORKER’s records (voice votes and unanimous consent are not roll calls; roll-call records start in 2011).

Cosponsors

33 cosponsors — 6 Republicans, 26 Democrats, 1 independent

8 of 33 cosponsors (24%) are from the other party.

Jesse Bingaman (D-NM), Barbara Boxer (D-CA), Robert Byrd (D-WV), Lincoln Chafee (R-RI), Hillary Clinton (D-NY), Susan Collins (R-ME), Kent Conrad (D-ND), Mark Dayton (D-MN), Richard Durbin (D-IL), Russell Feingold (D-WI), Dianne Feinstein (D-CA), Chuck Grassley (R-IA), Daniel Inouye (D-HI), James Jeffords (I-VT), Tim Johnson (D-SD), Edward Kennedy (D-MA), John Kerry (D-MA), Herbert Kohl (D-WI), Patrick Leahy (D-VT), Carl Levin (D-MI), Blanche Lincoln (D-AR), Chester Lott (R-MS), John McCain (R-AZ), Clarence Nelson (D-FL), Barack Obama (D-IL), Mark Pryor (D-AR), Ken Salazar (D-CO), Paul Sarbanes (D-MD), Charles Schumer (D-NY), Olympia Snowe (R-ME) and 3 more.

More from the sponsor

Other 109th Congress bills sponsored by Sen. Byron Dorgan.

Sponsor’s state and district

North Dakota in Congress

Open in Bill Explorer →

Data as of Sep 27, 2026 · bill record checked by PORKER from Congress.gov · votes from Senate.gov and the House Clerk. PORKER is non-partisan.